REQUEST A DEMO
Total
USD $0.00
Search more companies

Spect Medicina Nuclear Sas (Colombia)

Main Activities: Ambulatory Health Care Services
Full name: Spect Medicina Nuclear Sas Profile Updated: November 19, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Spect Medicina Nuclear Sas is a company based in Colombia, with its head office in Floridablanca. The enterprise operates in the Ambulatory Health Care Services industry. It was established on April 30, 1993. 17 (2024) employees currently work for Spect Medicina Nuclear Sas. There was a net sales revenue increase of 12.33% reported in Spect Medicina Nuclear Sas’s latest financial highlights for 2023. Its total assets grew by 3.92% over the same period. In, 2023, the company’s net profit margin increased by 5.73%.

Headquarters
Avenida El Bosque # 23 - 60 Piso 5 Torre B Modulo 43
Floridablanca; Santander;

Contact Details: Purchase the Spect Medicina Nuclear Sas report to view the information.

Basic Information
Total Employees:
Purchase the Spect Medicina Nuclear Sas report to view the information.
Outstanding Shares:
Purchase the Spect Medicina Nuclear Sas report to view the information.
Incorporation Date:
April 30, 1993
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Spect Medicina Nuclear Sas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
12.33%
Total operating revenue
12.33%
Operating profit (EBIT)
74.09%
Net Profit (Loss) for the Period
146.8%
Total assets
3.92%
Total equity
5.99%
Operating Profit Margin (ROS)
4.45%
Net Profit Margin
5.73%
Return on Equity (ROE)
6.69%
Debt to Equity Ratio
0.02%
Quick Ratio
0.68%
Cash Ratio
-0.47%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?